INM insider trading — InMed Pharmaceuticals Inc.
Over the last 90 days, insiders at InMed Pharmaceuticals Inc. (INM) made 12 open-market purchases worth $202K and 0 open-market sales worth $0, making them net buyers by $202K. The largest purchase was by Adar1 Capital Management, Llc, Schneeberger Daniel (10% Owner), who bought 54,256 shares for $70K on Sep 15, 2026.
Updated Oct 16, 2026.
Recent INM insider transactions
Every Form 4 filed by InMed Pharmaceuticals Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 984 | $1.32 | $1K | Form 4 |
| Oct 14, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 8,021 | $1.33 | $11K | Form 4 |
| Oct 13, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 564 | $1.33 | $750 | Form 4 |
| Oct 8, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 2,256 | $1.33 | $3K | Form 4 |
| Oct 7, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 3,046 | $1.33 | $4K | Form 4 |
| Oct 6, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 5,601 | $1.33 | $7K | Form 4 |
| Oct 5, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 18,182 | $1.33 | $24K | Form 4 |
| Oct 2, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 8,307 | $1.33 | $11K | Form 4 |
| Oct 1, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 16,431 | $1.33 | $22K | Form 4 |
| Sep 16, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 8,340 | $1.29 | $11K | Form 4 |
| Sep 15, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 54,256 | $1.30 | $70K | Form 4 |
| Sep 14, 2026 | Adar1 Capital Management, Llc, Schneeberger Daniel | 10% Owner | P · Purchase | Indirect | 28,505 | $1.29 | $37K | Form 4 |
INM insider trading FAQ
Are insiders buying INM stock?
Yes. In the last 90 days, InMed Pharmaceuticals Inc. insiders made 12 open-market purchases totaling $202K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading INM?
Recent buyers: Adar1 Capital Management, Llc, Schneeberger Daniel.
Where does INM insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.